Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Enoxaparin (severe)
Vitamin E (moderate)
Heparin (severe)
Alteplase (severe)
Bivalirudin (moderate)
Dabigatran (severe)
Streptokinase (severe)
Anisindione (severe)
Dipyridamole (severe)
Celecoxib (moderate)
Citalopram (severe)
Desvenlafaxine (moderate)
Apixaban (severe)
Ibuprofen (moderate)
Fondaparinux (severe)
Diclofenac (moderate)
Aspirin (moderate)
Acalabrutinib (severe)
Ardeparin (severe)
This medicine is used as an adjunct in patients undergoing surgical procedures including percutaneous coronary intervention, balloon angioplasty, stent placement, etc. to prevent the formation of blood clots and associated complications.
This medicine is used to treat patients with unstable angina who are unresponsive to conventional therapy and who are scheduled to undergo percutaneous coronary intervention within 24 hours.
Bleeding (Severe)
Blurred vision (Severe)
Dizziness when getting up suddenly from a sitting position
Excessive sweating
Unusual tiredness or weakness
Black or tarry stools (Severe)
Bleeding gums (Severe)
Pinpoint red spots on skin
Chest pain or discomfort
Fever and chills
Eye pain and discomfort (rare)
Headache
Pale skin (Severe)
Rapid weight gain
Swelling of hands and feet (Severe)
This medicine is not recommended for use in patients with a known allergy to Reopro Injection 10 mg 1 Vial or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with a history of cerebrovascular accidents within the past 2 years due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with active internal bleeding due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with thrombocytopenia (abnormally low number of platelets) due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with severe uncontrolled hypertension due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients who have recently received any oral anticoagulants (within the past 7 days), unless the prothrombin time is lesser than or equal to 1.2, due to the increased risk of excessive bleeding.
This medicine is not recommended for use in patients with peptic ulcer disease due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients suffering from an intracranial neoplasm due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients who have undergone major surgery or trauma within the past 6 weeks due to the increased risk of worsening of the patient’s condition.